UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders

Current medicinal chemistry, 2022-01, Vol.29 (27), p.4698-4737

2022

Volltextzugriff (PDF)

Special Issue "Adenosine Receptors as Attractive Targets in Human Diseases"

Pharmaceuticals (Basel, Switzerland), 2021-02, Vol.14 (2), p.140

2021

Volltextzugriff (PDF)

Piperazine- and Piperidine-Containing Thiazolo[5,4-d]pyrimidine Derivatives as New Potent and Selective Adenosine A2A Receptor Inverse Agonists

Pharmaceuticals (Basel, Switzerland), 2020-07, Vol.13 (8), p.161

2020

Volltextzugriff (PDF)

Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455

Frontiers in pharmacology, 2017-12, Vol.8, p.888-888

2017

Volltextzugriff (PDF)

Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta

Pharmaceuticals (Basel, Switzerland), 2024-04, Vol.17 (4), p.468

2024

Volltextzugriff (PDF)

“Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies

Pharmaceuticals (Basel, Switzerland), 2023-01, Vol.16 (2), p.167

2023

Volltextzugriff (PDF)

4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives

Pharmaceuticals (Basel, Switzerland), 2022-04, Vol.15 (4), p.478

2022

Volltextzugriff (PDF)

Competitive AMPA receptor antagonists

Medicinal research reviews, 2007-03, Vol.27 (2), p.239-278

2007

Volltextzugriff (PDF)

Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors. Ranging from Pan Ligands to Combined A1/A2B Partial Agonists

Pharmaceuticals (Basel, Switzerland), 2019-10, Vol.12 (4), p.159

2019

Volltextzugriff (PDF)

Pharmacological Characterization of P626, a Novel Dual Adenosine A2A/A2B Receptor Antagonist, on Synaptic Plasticity and during an Ischemic-like Insult in CA1 Rat Hippocampus

Biomolecules (Basel, Switzerland), 2023-05, Vol.13 (6), p.894

2023

Volltextzugriff (PDF)

Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives with High Affinity for Both the Adenosine A1 and A2A Receptors, and Efficacy in Animal Models of Depression

Pharmaceuticals (Basel, Switzerland), 2021-07, Vol.14 (7), p.657

2021

Volltextzugriff (PDF)

The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles

Journal of enzyme inhibition and medicinal chemistry, 2017-01, Vol.32 (1), p.248-263

2017

Volltextzugriff (PDF)

Novel AMPA and kainate receptor antagonists containing the pyrazolo[1,5- c]quinazoline ring system: Synthesis and structure–activity relationships

Bioorganic & medicinal chemistry, 2008-03, Vol.16 (5), p.2617-2626

2008

Volltextzugriff (PDF)

1,2,4-Triazolo[1,5-a]quinoxaline as a Versatile Tool for the Design of Selective Human A3 Adenosine Receptor Antagonists: Synthesis, Biological Evaluation, and Molecular Modeling Studies of 2-(Hetero)aryl- and 2-Carboxy-Substitued Derivatives

Journal of medicinal chemistry, 2005-12, Vol.48 (25), p.7932-7945

2005

Volltextzugriff (PDF)

Structural Investigation of the 7-Chloro-3-hydroxy-1H-quinazoline-2,4-dione Scaffold to Obtain AMPA and Kainate Receptor Selective Antagonists. Synthesis, Pharmacological, and Molecular Modeling Studies

Journal of medicinal chemistry, 2006-10, Vol.49 (20), p.6015-6026

2006

Volltextzugriff (PDF)

4-Amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as New Potent and Selective Human A3 Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand−Receptor Modeling Studies

Journal of medicinal chemistry, 2006-06, Vol.49 (13), p.3916-3925

2006

Volltextzugriff (PDF)

1,2,4-Triazolo[4,3-a]quinoxalin-1-one Moiety as an Attractive Scaffold To Develop New Potent and Selective Human A3 Adenosine Receptor Antagonists: Synthesis, Pharmacological, and Ligand−Receptor Modeling Studies

Journal of medicinal chemistry, 2004-07, Vol.47 (14), p.3580-3590

2004

Volltextzugriff (PDF)

Competitive Gly/NMDA receptor antagonists

Current topics in medicinal chemistry, 2006-04, Vol.6 (8), p.809-821

2006

Volltextzugriff (PDF)

Synthesis and Biological Evaluation of a New Set of Pyrazolo[1,5-c]quinazoline-2-carboxylates as Novel Excitatory Amino Acid Antagonists

Journal of medicinal chemistry, 2002-02, Vol.45 (5), p.1035-1044

2002

Volltextzugriff (PDF)

CK1 delta inhibition: an emerging strategy to combat neurodegenerative diseases

Future medicinal chemistry, 2022-08, Vol.14 (15), p.1111-1113

2022

Volltextzugriff (PDF)

A 2A Adenosine Receptor Antagonists and their Potential in Neurological Disorders

Current medicinal chemistry, 2022-08, Vol.29 (28), p.4780-4795

2022

Volltextzugriff (PDF)

Design, Synthesis, and Pharmacological Characterization of 2‑(2-Furanyl)thiazolo[5,4‑d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity

Journal of medicinal chemistry, 2016-12, Vol.59 (23), p.10564-10576

2016

Volltextzugriff (PDF)

Synthesis and Structure−Activity Relationships of a New Set of 2-Arylpyrazolo[3,4-c]quinoline Derivatives as Adenosine Receptor Antagonists

Journal of medicinal chemistry, 2000-08, Vol.43 (16), p.3118-3124

2000

Volltextzugriff (PDF)

Pharmacological Characterization of Some Selected 4,5-Dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates and 3-Hydroxyquinazoline-2,4-diones as (S)-2-Amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic Acid Receptor Antagonists

Chemical and Pharmaceutical Bulletin, 2010/07/01, Vol.58(7), pp.908-911

2010

Volltextzugriff (PDF)

The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2B receptor

European journal of medicinal chemistry, 2018-04, Vol.150, p.127-139

2018

Volltextzugriff (PDF)

1 – 25 von 158

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(153)

Publikationsform

Artikel
(156)
Buchkapitel
(2)

Sprache

Englisch
(158)

Erscheinungsjahr

n.n

Thema

Animals
(54)
Life Sciences & Biomedicine
(52)
Science & Technology
(52)
Structure-Activity Relationship
(51)
Pharmacology & Pharmacy
(47)
Chemistry, Medicinal
(44)
Humans
(40)
Biological And Medical Sciences
(38)
Medical Sciences
(38)
Pharmacology. Drug Treatments
(38)
Neuropharmacology
(37)
Neurotransmitters. Neurotransmission. Receptors
(37)
Rats
(25)
G Protein-Coupled Receptors
(22)
Chemistry
(21)
Physical Sciences
(21)
Cho Cells
(20)
Adenosine Receptor Antagonists
(19)
Ligands
(19)
Models, Molecular
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders

Special Issue "Adenosine Receptors as Attractive Targets in Human Diseases"

Piperazine- and Piperidine-Containing Thiazolo[5,4-d]pyrimidine Derivatives as New Potent and Selective Adenosine A2A Receptor Inverse Agonists

Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455

Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta

“Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies

4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives

Competitive AMPA receptor antagonists

Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors. Ranging from Pan Ligands to Combined A1/A2B Partial Agonists

Pharmacological Characterization of P626, a Novel Dual Adenosine A2A/A2B Receptor Antagonist, on Synaptic Plasticity and during an Ischemic-like Insult in CA1 Rat Hippocampus

Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives with High Affinity for Both the Adenosine A1 and A2A Receptors, and Efficacy in Animal Models of Depression

The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles

Novel AMPA and kainate receptor antagonists containing the pyrazolo[1,5- c]quinazoline ring system: Synthesis and structure–activity relationships

1,2,4-Triazolo[1,5-a]quinoxaline as a Versatile Tool for the Design of Selective Human A3 Adenosine Receptor Antagonists: Synthesis, Biological Evaluation, and Molecular Modeling Studies of 2-(Hetero)aryl- and 2-Carboxy-Substitued Derivatives

Structural Investigation of the 7-Chloro-3-hydroxy-1H-quinazoline-2,4-dione Scaffold to Obtain AMPA and Kainate Receptor Selective Antagonists. Synthesis, Pharmacological, and Molecular Modeling Studies

4-Amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as New Potent and Selective Human A3 Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand−Receptor Modeling Studies

1,2,4-Triazolo[4,3-a]quinoxalin-1-one Moiety as an Attractive Scaffold To Develop New Potent and Selective Human A3 Adenosine Receptor Antagonists: Synthesis, Pharmacological, and Ligand−Receptor Modeling Studies

Competitive Gly/NMDA receptor antagonists

Synthesis and Biological Evaluation of a New Set of Pyrazolo[1,5-c]quinazoline-2-carboxylates as Novel Excitatory Amino Acid Antagonists

CK1 delta inhibition: an emerging strategy to combat neurodegenerative diseases

A 2A Adenosine Receptor Antagonists and their Potential in Neurological Disorders

Design, Synthesis, and Pharmacological Characterization of 2‑(2-Furanyl)thiazolo[5,4‑d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity

Synthesis and Structure−Activity Relationships of a New Set of 2-Arylpyrazolo[3,4-c]quinoline Derivatives as Adenosine Receptor Antagonists

Pharmacological Characterization of Some Selected 4,5-Dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates and 3-Hydroxyquinazoline-2,4-diones as (S)-2-Amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic Acid Receptor Antagonists

The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2B receptor

Suchergebnisse filtern